Unlike prior observations in both pediatric and adult ALL, suggesting that DUX4-r was associated with favorable outcome,9,39 only 1 of 8 were MRD-positive at the end of induction, and 5 of 8 relapsed (supplemental Figure 10). Here, DUX4 is linked to acute lymphoblastic leukemia.